User profiles for Alimuddin Zumla
 | Professor Sir Alimuddin ZumlaUniversity College London Verified email at ucl.ac.uk Cited by 83078 |
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
…, RF Al-Hakeem, HQ Makhdoom, AI Zumla… - The Lancet infectious …, 2013 - thelancet.com
Background Middle East respiratory syndrome (MERS) is a new human disease caused by
a novel coronavirus (CoV). Clinical data on MERS-CoV infections are scarce. We report …
a novel coronavirus (CoV). Clinical data on MERS-CoV infections are scarce. We report …
Advances in the development of new tuberculosis drugs and treatment regimens
Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid,
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …
Middle East respiratory syndrome
Middle East respiratory syndrome (MERS) is a highly lethal respiratory disease caused by a
novel single-stranded, positive-sense RNA betacoronavirus (MERS-CoV). Dromedary …
novel single-stranded, positive-sense RNA betacoronavirus (MERS-CoV). Dromedary …
Coronaviruses—drug discovery and therapeutic options
In humans, infections with the human coronavirus (HCoV) strains HCoV-229E, HCoV-OC43,
HCoV-NL63 and HCoV-HKU1 usually result in mild, self-limiting upper respiratory tract …
HCoV-NL63 and HCoV-HKU1 usually result in mild, self-limiting upper respiratory tract …
Reducing mortality from 2019-nCoV: host-directed therapies should be an option
The number of confirmed cases of the 2019 novel coronavirus (2019-nCoV) reported to
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses, …
WHO continues to rise worldwide. 1 As with two other WHO Blueprint priority coronaviruses, …
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China
The city of Wuhan in China is the focus of global attention due to an outbreak of a febrile
respiratory illness due to a coronavirus 2019-nCoV. In December 2019, there was an outbreak …
respiratory illness due to a coronavirus 2019-nCoV. In December 2019, there was an outbreak …
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
About 1·3 million people died of tuberculosis in 2012, despite availability of effective drug
treatment. Barriers to improvements in outcomes include long treatment duration (resulting in …
treatment. Barriers to improvements in outcomes include long treatment duration (resulting in …
[BOOK][B] Manson's tropical diseases
GC Cook, A Zumla - 2009 - books.google.com
… Cook and Alimuddin I. Zumla to be identified as authors of this work has been asserted
by them in accordance with the Copyright, Designs and Patents Act 1988. … Zumla 1039 …
by them in accordance with the Copyright, Designs and Patents Act 1988. … Zumla 1039 …
Severe acute respiratory syndrome: historical, epidemiologic, and clinical features
Over the past 2 decades 2 previously unknown coronaviruses (CoVs), the severe acute
respiratory syndrome CoV (SARS-CoV) and the Middle East respiratory syndrome CoV (MERS-…
respiratory syndrome CoV (SARS-CoV) and the Middle East respiratory syndrome CoV (MERS-…
The WHO 2014 global tuberculosis report—further to go
A Zumla, A George, V Sharma, RHN Herbert… - The Lancet Global …, 2015 - thelancet.com
In May 2014, the World Health Assembly officially approved the Draft Global Strategy and
Targets for Tuberculosis Prevention, Care and Control after 2015. 1 The target of the strategy …
Targets for Tuberculosis Prevention, Care and Control after 2015. 1 The target of the strategy …
